4D Molecular Therapeutics IncEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 9.85 USD | 14 USD | 4,3 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 28,222 USD | 5 | 4 | 2 | 0 | 1 |
| #Shares | Short [%] | Short Ratio |
| 52.276.254 | 25,13 | 10,28 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name 4D Molecular Therapeutics Inc
Mitarbeiter 196
Handelsplatz NASDAQ
Ticker Symbol FDMT
IPO Datum 2020-12-11
Adresse 5858 Horton Street, EmeryVille, CA, United States, 94608
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. John F. Milligan Ph.D. | Executive Chairman |
| 2 | Dr. David H. Kirn M.D. | Co-Founder, President, CEO & Director |
| 3 | Mr. Kristian Humer M.B.A. | CFO and Principal Financial & Accounting Officer |
| 4 | Dr. Fariborz Kamal Ph.D. | Chief Technical Advisor |
| 5 | Ms. Theresa Janke | Co-Founder & Chief of Staff |
| 6 | Julian Pei | Head of Investor Relations & Corporate Finance |
| 7 | Dr. Katy Barglow Ph.D. | Chief Technical Officer |
| 8 | Dr. Scott P. Bizily J.D., Ph.D. | Chief Legal Officer & Corporate Secretary |
| 9 | Dr. An Song Ph.D. | Chief Translational Medicine Advisor |
| 10 | Dr. Noriyuki Kasahara M.D., Ph.D. | Chief Scientific Advisor |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 2 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 3 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 5 | Novo A/S | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 7 | Bvf Inc | 0,00% | 0,00 Mio. USD |
| 8 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 9 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 12 | Federated Hermes Inc | 0,00% | 0,00 Mio. USD |
| 13 | Trails Edge Capital Partners, LP | 0,00% | 0,00 Mio. USD |
| 14 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 16 | Deutsche Bank AG | 0,00% | 0,00 Mio. USD |
| 17 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 18 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 20 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |